MyMedR

Displaying all 4 publications

Abstract:

Sort:

Fulltext Ex Utero Intrapartum Treatment (EXIT) Into the World: A Multidisciplinary Approach and Outcomes in a Malaysia Tertiary Centre

Oon A, Zulkifli S, Foong YK, Azhar AS, Abdul Ghafar MH, Soo MY

Indian J Otolaryngol Head Neck Surg, 2022 Jun;74(2):190-195.
PMID: 35813785 DOI: 10.1007/s12070-021-02851-y

Fetal airway obstruction that present during birth are challenging to manage. Cervical and thoracic mass may cause significant airway compression that leads to irreversible fetal morbidity and mortality. With the current advancement in prenatal diagnosis and assessment for surgical planning, EXIT has become an accepted, recognized and preferred option for safe delivery in complex head and neck masses. Ex utero intrapartum treatment (EXIT) is a life-saving procedure that provides time to establish an airway while maintaining uteroplacental circulation. It requires flawless coordination amongst multidisciplinary team to ensure immediate and safe baby deliveries. Retrospective review of EXIT procedures performed from the initial establishment of pediatric otolaryngology service in this centre starting from January 2019 to December 2020. Based on the prenatal diagnosis, five EXIT cases were performed in this centre within 2 years. 4 cases were diagnosed as lymphatic malformation and 1 immature teratoma with cervical and thoracic compression. 4 babies successfully delivered to airway without any complications with 1 death resulting from disseminated intravascular coagulopathy after EXIT. This review of five EXIT procedures aims to bring forth the different outcomes, preoperative planning and sharing our experience as a tertiary and newly established centre. Early prenatal diagnosis, good collaboration and experience among multidisciplinary team ensures good long term outcomes.
Tinnitus Evaluation in Type 1 Diabetes Mellitus at Tertiary Hospital Malaysia

Ameen SA, Norasyikin AW, Dina HN, Zara MNF, Tyler R, Asma A

Int Tinnitus J, 2022 Dec 01;26(2):89-94.
PMID: 36724354 DOI: 10.5935/0946-5448.20220013

OBJECTIVES: To determine the prevalence of tinnitus in Type 1 Diabetes Mellitus (T1DM) patients, to evaluate its severity and to correlate it with estimated Glomerular Filtration Rate (eGFR) as well as glycaemia control (HbA1c).
MATERIAL AND METHODS: We performed a questionnaire-based cross-sectional study at Hospital Canselor Tuanku Muhriz (HCTM) from a period of 15 months. A total of 133 T1DM patients who fulfilled our study's criteria were subjected to otoscopy examination, tuning fork test and free field voice test. The mini-Tinnitus Questionnaire (TQ) was used to assess the severity of tinnitus. We were careful to categorize the perceived duration of tinnitus.
RESULTS: The prevalence of tinnitus among T1DM patients was 24.1% (32/133 patients). Out of 32 patients, approximately 78.1% (25 patients) had a compensated level of tinnitus distress and the remaining 21.9% (7/32) had moderate tinnitus. The duration of tinnitus ranged from 2 seconds to 2 minutes, whıch was ringing and intermittent in nature. The HbA1c and estimated Glomerular Filtration Rate (eGFR) were higher in tinnitus compared to the non-tinnitus group. There was no significant correlation between the severity of tinnitus and HbA1c level or eGFR.
CONCLUSIONS: Our study concluded that tinnitus amongst T1DM patients was likely to be non-pathological in view of its short duration with minimal to no distress to the sufferers. An elevated HbA1c may increase the risk of developıng tinnitus.
Plant extract-based green fabrication of nickel ferrite (NiFe2O4) nanoparticles: An operative platform for non-enzymatic determination of pentachlorophenol

Taqvi SIH, Solangi AR, Buledi JA, Khand NH, Junejo B, Memon AF, et al.

Chemosphere, 2022 Jan 28;294:133760.
PMID: 35092751 DOI: 10.1016/j.chemosphere.2022.133760

Environmental pollution has become a major human concern with the extensive exploitation of pesticides. Pentachlorophenol (PCP) is the most hazardous of all chlorophenols which are being used as pesticide, fungicide, and wood preservative. Thus, the fabrication of ultrasensitive electrochemical methods for the determination of pesticides is of great significance. In the present experiment, a simple, green, and sensitive electrochemical sensor was constructed for the determination of PCP by using a chemically modified nickel ferrite glassy carbon electrode (NiFe2O4/GCE). The fabricated nanoparticles were primarily characterized by several analytical tools to confirm the functionalities, surface texture, crystallinity, and elemental composition. For the investigation of conductive nature, the proposed NiFe2O4/GCE was exploited to the primary electrochemical characterization tools e.g. Cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). The ultra-sensitive determination of PCP was carried out under the linear dynamic range from 0.01 to 90 μM at the pulse amplitude of 80 mV/s in BRB buffer pH of 4. The limit of detection of the developed methods for PCP was calculated to be 0.0016 μM. The analytical applicability of the fabricated sensor was tested in different water samples depicting the acceptable recovery values.
Experimental drugs in randomized controlled trials for long-COVID: what's in the pipeline? A systematic and critical review

Yong SJ, Halim A, Halim M, Ming LC, Goh KW, Alfaresi M, et al.

Expert Opin Investig Drugs, 2023;32(7):655-667.
PMID: 37534972 DOI: 10.1080/13543784.2023.2242773

INTRODUCTION: Over three years have passed since the emergence of coronavirus disease 2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome, remains long overdue. Currently, there is no standardized treatment available for long-COVID, primarily due to the lack of funding for post-acute infection syndromes (PAIS). Nevertheless, the past few years have seen a renewed interest in long-COVID research, with billions of dollars allocated for this purpose. As a result, multiple randomized controlled trials (RCTs) have been funded in the quest to find an effective treatment for long-COVID.
AREAS COVERED: This systematic review identified and evaluated the potential of current drug treatments for long-COVID, examining both completed and ongoing RCTs.
EXPERT OPINION: We identified four completed and 22 ongoing RCTs, investigating 22 unique drugs. However, most drugs were deemed to not have high potential for treating long-COVID, according to three pre-specified domains, a testament to the ordeal of treating long-COVID. Given that long-COVID is highly multifaceted with several proposed subtypes, treatments likely need to be tailored accordingly. Currently, rintatolimod appears to have modest to high potential for treating the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) subtype, LTY-100 and Treamid for pulmonary fibrosis subtype, and metformin for general long-COVID prevention.